We have seen that costs associated with GLP-1 agonists are continuing to rise, and cost-based decisions are being made by public and private insurers, as well as employers as utilization increases and organizations work to manage or contain costs, said Rita Glaze-Rowe, president of transformative healthcare markets at Real Chemistry, in a statement
Future outlook for peptide ecommerce The peptide market continues evolving
[176] An analysis of events in the US FDA Adverse Event Reporting System suggests an association between several GLP-1 agonists (including semaglutide) and cutaneous reactions, such as dermal hypersensitivity reactions, eosinophilic panniculitis, bullous pemphigoid, and morbilliform drug eruptions
The bill did not get traction after it was introduced during the regular 2024 legislative session
When to Speak with Your GP About Supplementation Whilst over-the-counter multivitamins are widely available and generally considered safe, men over 40 taking GLP-1 medications should consult their GP or prescribing clinician before starting supplementation in several specific circumstances
